TritonPoint Wealth’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$336K Sell
3,844
-170
-4% -$16.3K 0.04% 208
2025
Q4
$388K Sell
4,014
-1,737
-30% -$169K 0.04% 199
2025
Q3
$552K Buy
5,751
+181
+3% +$16.6K 0.05% 209
2025
Q2
$490K Sell
5,570
-1,110
-17% -$94.1K 0.05% 216
2025
Q1
$605K Buy
6,680
+1,118
+20% +$100K 0.06% 193
2024
Q4
$448K Sell
5,562
-810
-13% -$70.1K 0.04% 220
2024
Q3
$574K Sell
6,372
-5,225
-45% -$440K 0.05% 197
2024
Q2
$921K Sell
11,597
-2,618
-18% -$215K 0.09% 151
2024
Q1
$1.05M Buy
14,215
+1,398
+11% +$119K 0.11% 142
2023
Q4
$1.06M Buy
+12,817
New +$977K 0.1% 144

Other funds holding MDT

TritonPoint Wealth's MDT Position: Q1 2026 in Review

TritonPoint Wealth reduced its Medtronic (MDT) stake by 4.2% in Q1 2026, selling an estimated $16.3K and leaving 3,844 shares worth $336K. The position accounts for 0.04% of the portfolio, ranked #208.

TritonPoint Wealth first reported a position in MDT in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.06M in Q4 2023. 2,230 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • TritonPoint Wealth held 3,844 shares of Medtronic worth $336K as of Q1 2026.
  • TritonPoint Wealth sold 170 Medtronic shares in Q1 2026, an estimated $16.3K.
  • Medtronic made up 0.04% of TritonPoint Wealth's portfolio in Q1 2026, its #208 holding.
  • TritonPoint Wealth first reported a position in Medtronic in Q4 2023 and has held it in 10 quarters since.
  • TritonPoint Wealth's Medtronic position peaked at $1.06M in Q4 2023.
  • 2,230 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on TritonPoint Wealth's 13F filing for Q1 2026, filed 21 Apr 2026.